Single-Patient Expanded Access Protocol for Tradipitant in a Single Patient with Gastroparesis.”
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
1 participants needed
1 Location
Brief description of study
This study is not open to participants that have not completed the induction study.
This treatment plan is for a single patient with gastroparesis who has requested expanded access to tradipitant.
Gastroparesis is a condition where the stomach is unable to perform its normal functions. Individuals with gastroparesis have delayed gastric emptying, which means that food moves slower from the stomach to the small intestine. Individuals with gastroparesis can experience a number of symptoms, including:
• Nausea
• Vomiting (throwing up)
• Inability to finish a normal sized meal
• Excessive fullness after eating
• Pain in the stomach area
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Diabetic & Idiopathic Gastroparesis
-
Age: 18 years - 99 years
-
Gender: All
Identified subject, aged 18 or older; Diagnosed with idiopathic or diabetic gastroparesis by a physician Demonstrated delayed gastric emptying of a solid meal via either scintigraphy or gastric breath test, Presence of nausea symptom for at least 6 months prior to screening, Patient’s gastroparesis symptoms persist despite diet and/or life-style modifications; Patient does not qualify for or does not have access to other clinical trials with tradipitant
Updated on
04 Aug 2024.
Study ID: 850407
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
